These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26840258)

  • 1. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
    Wang JL; Wu DW; Cheng ZZ; Han WZ; Xu SW; Sun NN
    Asian Pac J Cancer Prev; 2014; 15(12):4865-9. PubMed ID: 24998555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
    Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
    Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
    Zhang X; Li P; Rong M; He R; Hou X; Xie Y; Chen G
    Tohoku J Exp Med; 2015 Mar; 235(3):161-9. PubMed ID: 25746592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
    Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
    Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X; Han S; Zhou H; Cai L; Li J; Liu N; Liu Y; Wang L; Fan C; Li A; Miao Y
    Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
    Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
    Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
    Deng B; Sun Z; Jason W; Yang P
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.